[BIOS] BioScrip, Inc.


Type of security: Stock

Sector: Health Care

Industry: Medical/Nursing Services

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.


Price: 1.03 Change: 0.01 (0.98%)
Ext. hours: Change: 0 (0%)

chart BIOS

Refresh chart

Strongest Trends Summary For BIOS

BIOS is in the long-term up 47% in 3 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart


Description: BioScrip, Inc. provides home infusion and other home care services, and pharmacy benefit management (PBM) services in the United States. It operates in three segments: Infusion Services, Home Health Services, and PBM Services. The Infusion Services segment offers home infusion and respiratory therapy services; and durable medical equipment, products, and services. Its home infusion services include the intravenous administration of medications to treat various acute and chronic conditions, such as infections, nutritional deficiencies, immunologic and neurologic conditions, cancer, pain, and palliative care. This segment offers services, including the dispensing and administering of infusion-based drugs, which require nursing support and clinical management services; equipment to administer the dosage; and patient training. The Home Health Services segment provides skilled nursing, wound care, oncology nursing and infusion nursing, medical social services, home health aide services, private duty nursing care,

Fundamental Ratios
Shares Outstanding EPS-0.42 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 5.89% Sales Growth - Q/Q3.15% P/E-6.02
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-16.78% ROE-54.92% ROI-22.68%
Current Ratio1.46 Quick Ratio1.17 Long Term Debt/Equity6.23 Debt Ratio0.56
Gross Margin26.08% Operating Margin-8.41% Net Profit Margin-14.09% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities52.62 M Cash From Investing Activities-2.07 M Cash From Operating Activities-28.05 M Gross Profit66.47 M
Net Profit-19.67 M Operating Profit-4.81 M Total Assets845.42 M Total Current Assets212.35 M
Total Current Liabilities145.16 M Total Debt418.83 M Total Liabilities587.2 M Total Revenue261.68 M
Technical Data
High 52 week3.26 Low 52 week2.14 Last close3.23 Last change2.87%
RSI71.58 Average true range0.16 Beta0.74 Volume903.26 K
Simple moving average 20 days6.82% Simple moving average 50 days7.12% Simple moving average 200 days14.23%
Performance Data
Performance Week1.25% Performance Month16.19% Performance Quart11.38% Performance Half28.69%
Performance Year30.24% Performance Year-to-date11% Volatility daily3.7% Volatility weekly8.27%
Volatility monthly16.95% Volatility yearly58.71% Relative Volume179.15% Average Volume453.59 K
New High New Low


2019-03-18 16:44:11 | BioScrip, Inc. -- Moody's places BioScrip's ratings under review for upgrade following the announced merger with HC Group Holdings

2019-03-18 12:23:00 | BioScrip's stock extends plunge after merger terms disappoint, but analyst recommends remaining bullish

2019-03-18 08:51:12 | BioScrip BIOS Reports Loss in Q4, Both Margins Contract

2019-03-18 08:44:12 | Do Options Traders Know Something About BioScrip BIOS Stock We Don't?

2019-03-15 17:42:24 | Edited Transcript of BIOS earnings conference call or presentation 15-Mar-19 1:00pm GMT

2019-03-15 16:33:00 | Why Adobe, BioScrip, and Ascena Retail Group Slumped Today

2019-03-15 15:22:47 | Bioscrip Inc BIOS Q4 2018 Earnings Conference Call Transcript

2019-03-15 14:42:00 | Why BioScrip Stock Popped and Then Dropped Today

2019-03-15 09:32:00 | Infusion Therapy Firm BioScrip to Buy Rival Option Care

2019-03-15 07:35:00 | BioScrip's stock soars after merger deal with Option Care, owned by Walgreens and Madison Dearborn

2019-03-15 07:30:27 | BioScrip: 4Q Earnings Snapshot

2019-03-15 07:01:00 | BioScrip Reports Fourth Quarter and Full Year 2018 Financial Results

2019-03-15 07:00:00 | BioScrip, Inc. to Host Earnings Call

2019-03-15 07:00:00 | Home and Alternate Site Infusion Therapy Providers BioScrip and Option Care to Merge

2019-03-13 22:11:15 | BioScrip Reschedules Release of Fourth Quarter and Full Year 2018 Financial Results and Conference Call

2019-03-08 11:12:17 | What Kind Of Shareholders Own BioScrip, Inc. NASDAQ:BIOS?

2019-02-25 14:00:00 | BioScrip Schedules Release of Fourth Quarter and Full Year 2018 Financial Results and Conference Call

2019-01-22 07:25:00 | Report: Developing Opportunities within Macy's, Leggett & Platt, Tyler Technologies, BioScrip, DXC Technology, and STERIS plc — Future Expectations, Projections Moving into 2019

2019-01-03 09:00:00 | BioScrip to Present at the 37th Annual J.P. Morgan Healthcare Conference

2018-12-18 02:55:39 | Here is What Hedge Funds Think About BioScrip Inc. BIOS

2018-12-06 09:30:02 | Why Is BioScrip BIOS Up 18.7% Since Last Earnings Report?

2018-11-28 11:50:00 | Biomedical Trends Fuel New Momentum For Healthcare Stocks; Premier Health Group, Inc. OTC: PHGRF CSE: PHGI, Alliqua BioMedical, BioScrip, Coremedix

2018-11-26 16:30:00 | BioScrip to Host Analyst and Investor Day

2018-11-26 12:55:00 | 4 Healthcare Stocks Seeing New Highs On Monday

2018-11-20 09:00:00 | BioScrip to Present at the Bank of America Merrill Lynch 2018 Leveraged Finance Conference

2018-11-16 10:50:00 | 4 Healthcare Stocks Turning Toward Tech For New Growth

2018-11-09 10:18:03 | BioScrip BIOS Q3 Loss Wider Than Expected, Revenues Beat

2018-11-07 21:30:47 | Edited Transcript of BIOS earnings conference call or presentation 6-Nov-18 2:00pm GMT

2018-11-06 09:40:02 | BioScrip BIOS Reports Q3 Loss, Tops Revenue Estimates

2018-11-06 08:37:25 | BioScrip: 3Q Earnings Snapshot

2018-11-06 08:00:00 | BioScrip Reports Third Quarter 2018 Financial Results

2018-11-01 08:00:00 | BioScrip Comments on Implementation of Medicare Home Infusion Transition Benefit

2018-10-25 09:00:00 | BioScrip to Present at the 2018 Stephens NY Investment Conference

2018-10-25 08:25:00 | Factors of Influence in 2018, Key Indicators and Opportunity within Portola Pharmaceuticals, Cable One, Marriot Vacations Worldwide, United Technologies, Park-Ohio, and BioScrip — New Research Emphasizes Economic Growth

2018-10-24 09:00:00 | BioScrip Schedules Release of Third Quarter 2018 Financial Results and Conference Call

2018-10-22 16:30:00 | BioScrip Appoints John McMahon as Chief Accounting Officer

2018-10-10 10:29:02 | BioScrip Grows on CORE Plan, Reimbursement Issues Persist

2018-09-06 10:17:02 | BioScrip BIOS Up 4.8% Since Last Earnings Report: Can It Continue?

2018-09-05 09:00:00 | BioScrip to Participate in Upcoming Investor Conferences

2018-09-05 07:30:00 | Factors of Influence in 2018, Key Indicators and Opportunity within Aerie Pharmaceuticals, BioScrip, Celsion, Primoris Services, Cyclacel Pharmaceuticals, and Barnes Group — New Research Emphasizes Economic Growth

2018-08-16 08:25:00 | Factors of Influence in 2018, Key Indicators and Opportunity within BioScrip, Powell Industries, Portola Pharmaceuticals, Daktronics, Cable One, and Park-Ohio — New Research Emphasizes Economic Growth

2018-08-13 05:30:34 | Edited Transcript of BIOS earnings conference call or presentation 7-Aug-18 1:00pm GMT

2018-08-08 10:25:02 | BioScrip BIOS Q2 Loss Wider Than Expected, Revenues Top

2018-08-07 09:25:01 | BioScrip BIOS Reports Q2 Loss, Tops Revenue Estimates

2018-08-07 08:22:27 | BioScrip: 2Q Earnings Snapshot

2018-08-07 08:00:00 | BioScrip Reports Second Quarter 2018 Financial Results

2018-08-07 07:00:00 | BioScrip, Inc. to Host Earnings Call

2018-07-30 17:06:06 | BioScrip, Inc. -- Moody's upgrades BioScrip's CFR to Caa1; outlook stable

2018-07-30 15:31:18 | 5 Stocks In Bearish Trends This Week

2018-07-30 08:30:00 | BioScrip Appoints Leslie McIntosh as Chief Human Resources Officer